213 related articles for article (PubMed ID: 30189809)
1. Nonlamellar liquid crystals: a new paradigm for the delivery of small molecules and bio-macromolecules.
Urandur S; Marwaha D; Gautam S; Banala VT; Sharma M; Mishra PR
Ther Deliv; 2018 Sep; 9(9):667-689. PubMed ID: 30189809
[TBL] [Abstract][Full Text] [Related]
2. Non-Lamellar Lyotropic Liquid Crystalline Lipid Nanoparticles for the Next Generation of Nanomedicine.
Zhai J; Fong C; Tran N; Drummond CJ
ACS Nano; 2019 Jun; 13(6):6178-6206. PubMed ID: 31082192
[TBL] [Abstract][Full Text] [Related]
3. Recent patents on nonlamellar liquid crystalline lipid phases in drug delivery.
Koynova R; Tenchov B
Recent Pat Drug Deliv Formul; 2013 Dec; 7(3):165-73. PubMed ID: 23829393
[TBL] [Abstract][Full Text] [Related]
4. Current potential and challenges in the advances of liquid crystalline nanoparticles as drug delivery systems.
Madheswaran T; Kandasamy M; Bose RJ; Karuppagounder V
Drug Discov Today; 2019 Jul; 24(7):1405-1412. PubMed ID: 31102731
[TBL] [Abstract][Full Text] [Related]
5. Phytantriol based smart nano-carriers for drug delivery applications.
Akbar S; Anwar A; Ayish A; Elliott JM; Squires AM
Eur J Pharm Sci; 2017 Apr; 101():31-42. PubMed ID: 28137471
[TBL] [Abstract][Full Text] [Related]
6. Cubic lyotropic liquid crystals as drug delivery carriers: Physicochemical and morphological studies.
Chountoulesi M; Pippa N; Pispas S; Chrysina ED; Forys A; Trzebicka B; Demetzos C
Int J Pharm; 2018 Oct; 550(1-2):57-70. PubMed ID: 30121331
[TBL] [Abstract][Full Text] [Related]
7. Cubosomes and hexosomes as versatile platforms for drug delivery.
Azmi ID; Moghimi SM; Yaghmur A
Ther Deliv; 2015; 6(12):1347-64. PubMed ID: 26652281
[TBL] [Abstract][Full Text] [Related]
8. Nonlamellar liquid crystalline nanostructured particles: advances in materials and structure determination.
Boyd BJ; Dong YD; Rades T
J Liposome Res; 2009; 19(1):12-28. PubMed ID: 19515004
[TBL] [Abstract][Full Text] [Related]
9. Coupling in vitro cell culture with synchrotron SAXS to understand the bio-interaction of lipid-based liquid crystalline nanoparticles with vascular endothelial cells.
Lam YY; Hawley A; Tan A; Boyd BJ
Drug Deliv Transl Res; 2020 Jun; 10(3):610-620. PubMed ID: 31997254
[TBL] [Abstract][Full Text] [Related]
10. Modulatory effect of human plasma on the internal nanostructure and size characteristics of liquid-crystalline nanocarriers.
Azmi ID; Wu L; Wibroe PP; Nilsson C; Østergaard J; Stürup S; Gammelgaard B; Urtti A; Moghimi SM; Yaghmur A
Langmuir; 2015 May; 31(18):5042-9. PubMed ID: 25884233
[TBL] [Abstract][Full Text] [Related]
11. Lipid-Based Liquid Crystals As Carriers for Antimicrobial Peptides: Phase Behavior and Antimicrobial Effect.
Boge L; Bysell H; Ringstad L; Wennman D; Umerska A; Cassisa V; Eriksson J; Joly-Guillou ML; Edwards K; Andersson M
Langmuir; 2016 May; 32(17):4217-28. PubMed ID: 27033359
[TBL] [Abstract][Full Text] [Related]
12. Intrinsic and Dynamic Heterogeneity of Nonlamellar Lyotropic Liquid Crystalline Nanodispersions.
Yaghmur A; Moghimi SM
ACS Nano; 2023 Nov; 17(22):22183-22195. PubMed ID: 37943319
[TBL] [Abstract][Full Text] [Related]
13. Freeze-dried and re-hydrated liquid crystalline nanoparticles stabilized with disaccharides for drug-delivery of the plectasin derivative AP114 antimicrobial peptide.
Boge L; Västberg A; Umerska A; Bysell H; Eriksson J; Edwards K; Millqvist-Fureby A; Andersson M
J Colloid Interface Sci; 2018 Jul; 522():126-135. PubMed ID: 29587194
[TBL] [Abstract][Full Text] [Related]
14. Advances in drug delivery and medical imaging using colloidal lyotropic liquid crystalline dispersions.
Mulet X; Boyd BJ; Drummond CJ
J Colloid Interface Sci; 2013 Mar; 393():1-20. PubMed ID: 23237762
[TBL] [Abstract][Full Text] [Related]
15. Understanding the interfacial properties of nanostructured liquid crystalline materials for surface-specific delivery applications.
Dong YD; Larson I; Barnes TJ; Prestidge CA; Allen S; Chen X; Roberts CJ; Boyd BJ
Langmuir; 2012 Sep; 28(37):13485-95. PubMed ID: 22889049
[TBL] [Abstract][Full Text] [Related]
16. Self-assembled geometric liquid-crystalline nanoparticles imaged in three dimensions: hexosomes are not necessarily flat hexagonal prisms.
Boyd BJ; Rizwan SB; Dong YD; Hook S; Rades T
Langmuir; 2007 Dec; 23(25):12461-4. PubMed ID: 17988167
[TBL] [Abstract][Full Text] [Related]
17. Bioimaging Applications of Non-Lamellar Liquid Crystalline Nanoparticles.
Murgia S; Biffi S; Fornasier M; Lippolis V; Picci G; Caltagirone C
J Nanosci Nanotechnol; 2021 May; 21(5):2742-2759. PubMed ID: 33653441
[TBL] [Abstract][Full Text] [Related]
18. Self-assembled multicompartment liquid crystalline lipid carriers for protein, peptide, and nucleic acid drug delivery.
Angelova A; Angelov B; Mutafchieva R; Lesieur S; Couvreur P
Acc Chem Res; 2011 Feb; 44(2):147-56. PubMed ID: 21189042
[TBL] [Abstract][Full Text] [Related]
19. Tailoring liquid crystalline lipid nanomaterials for controlled release of macromolecules.
Bisset NB; Boyd BJ; Dong YD
Int J Pharm; 2015 Nov; 495(1):241-248. PubMed ID: 26319637
[TBL] [Abstract][Full Text] [Related]
20. Lipid polymorphism in lyotropic liquid crystals for triggered release of bioactives.
Garti N; Libster D; Aserin A
Food Funct; 2012 Jul; 3(7):700-13. PubMed ID: 22592749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
